DAS Therapeutics

Manufacturing · United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

United States

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About DAS Therapeutics

DAS Therapeutics, Inc. is a privately funded clinical stage pharmaceutical company focused on developing unique treatment options for conditions that are often overlooked or underserved. Their primary product, DAS-001, is an innovative combination therapy aimed at alleviating symptoms of Myasthenia Gravis, a chronic autoimmune disease affecting muscle strength. The company has successfully completed a Phase 1 study and is currently enrolling participants for Phase 2 clinical trials. DAS Therapeutics targets patients suffering from Myasthenia Gravis and seeks partnerships to further their mission of improving patient outcomes.Explore more
DAS Therapeutics's Social MediaPopular SearchesDAS TherapeuticsDAS Therapeutics IncSIC Code 28,283NAICS Code 32,325Show more

DAS Therapeutics Org Chart

PhoneEmail
RD
United States flag for contact location.

Founder & Chairman

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is DAS Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to DAS Therapeutics

Compare insights from companies similar to DAS Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

DAS Therapeutics

<$5M
1-10
Private
-
-
RD
Raimonds DzelmeFounder & Chairman
<$5M
11-50
Private
-
2006
N/A
<$5M
1-10
Private
-
2013
Ketan Desai, Chief Medical Officer at Levolta Pharmaceuticals
Ketan DesaiChief Medical Officer
<$5M
11-50
Private
-
2012
<$5M
11-50
Private
-
2012
AI
Anita IlchevaChief Financial Officer
<$5M
1-10
Private
<$5M
2017
JK
James KirwinChief Operating Officer & Senior VP, Clinical Development
<$5M
1-10
Private
-
2004
N/A
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

DAS Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

DAS Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about DAS Therapeutics.

DAS Therapeutics Tech Stack

A closer look at the technologies used by DAS Therapeutics

Top Manufacturing Companies

Frequently Asked Questions Regarding DAS Therapeutics

What is DAS Therapeutics's official website?
DAS Therapeutics's official website is www.dastherapeutics.com
What is DAS Therapeutics's Revenue?
DAS Therapeutics's revenue is <$5 Million
What is DAS Therapeutics's SIC code?
DAS Therapeutics's SIC: 28,283
What is DAS Therapeutics's NAICS code?
DAS Therapeutics's NAICS: 32,325
How many employees does DAS Therapeutics have?
DAS Therapeutics has 1-10 employees
What industry does DAS Therapeutics belong to?
DAS Therapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is DAS Therapeutics competition?
DAS Therapeutics top competitors include: Sofpromed, SFA Therapeutics, Speid & Associates, Novadiol
What technology does DAS Therapeutics use?
Some of the popular technologies that DAS Therapeutics uses are: Google Font API, Microsoft 365, GoDaddy DNS, Starfield Technologies
What does DAS Therapeutics do?

DAS Therapeutics, Inc. is a privately funded clinical stage pharmaceutical company focused on developing unique treatment options for conditions that are often overlooked or underserved. Their primary product, DAS-001, is an innovative combination therapy aimed at alleviating symptoms of Myasthenia Gravis, a chronic autoimmune disease affecting mus... cle strength. The company has successfully completed a Phase 1 study and is currently enrolling participants for Phase 2 clinical trials. DAS Therapeutics targets patients suffering from Myasthenia Gravis and seeks partnerships to further their mission of improving patient outcomes.Read More

What are DAS Therapeutics social media links?
DAS Therapeutics Linkedin page
Is DAS Therapeutics a public company?
DAS Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about DAS Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.